February 3, 2016

Colorectal Cancer: Year in Review

By Anonymous User

After several years of exciting developments in colorectal cancer research and therapy, progress continued throughout 2015. The FDA approved a new drug to treat colorectal cancer, and much research has been done with combination therapies and protocols for treatment. Of great importance, research shows that when colorectal cancer is detected during a screening colonoscopy, patients who screen positive are more likely to live longer than patients who wait for a screening until they have symptoms. Death rates from colorectal cancer have declined in the past 10 years which is thought to be due to increased screening and newer drugs to treat the disease. However, colorectal cancer remains the second leading cause of cancer-related deaths in the U.S.

CancerConnect News coverage of advances in the management of colorectal cancer included the following key developments:

2015 FDA Approvals

2015 Colon Cancer Research News

Screening and Prevention




 Knowledge is Power 

Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?

  • Sign up for monthly newsletters on colorectal cancer here.
  • Get the facts about colorectal cancer here.
  • Join the CancerConnect online support group to join ongoing discussions with other individuals affected by colorectal cancer here.
  • Follow CancerConnect on Facebook and Twitter.

Copyright © 2019 CancerConnect. All Rights Reserved.

Tags: Colon Cancer, News Tips and Features, News Tips and Features Other, Rectal Cancer